|
|
||||||||
|
|
|||||||||
|
|
Cardiovascular: Clinical ScienceClinical Science Posters |
1 Nuc Medicine; 2 Rad Onc; 3 Rad Physics; 4 Cardiology, MD Anderson Cancer Center, Houston, Texas
|
|
864
Objectives: To investigate the clinical implications of radiation therapy (RT) related myocardial perfusion Imaging (MPI) abnormalities in patients with esophageal cancer (EC)& Lung Cancer (LC).
Methods: We retrospectively compared the results of 15 patients with EC & 22 patients with LC who had MPI before and after chemoradiation therapy(CRT).New MPI defects in the RT field were considered related to RT.Followup was done to evaluate for cardiac complications.
Results: 15 patients with EC & 22 with LC were included.The mean radiation dose to the heart was 29.6 Gy in EC & 17.6 Gy in LC,the mean heart volume involved was 746.6cc & 654.2cc in EC and LC respectively.All EC patients had normal pre-RT MPI results except 2.Repeat MPI studies were performed at a mean interval of 7.2 mo from end of RT.6 patients showed abnormal MPI of whom 2 remained asymptomatic,2 developed Afib after surgery but remained alive,1 developed chest pain but remained alive and 1 developed bradycardia,AV block & expired from heart failure.In the LC group,all except 1 had normal pre-RT MPI results.Repeat MPI studies were performed at a mean interval of 7.3 mo from end of RT.Of the 22 patients,7 showed abnormal MPI,of whom 3 remained asymptomatic & alive,2 developed AF & died due to stroke & mets to the brain,1 developed chest pain but remained alive and 1 developed pericardial effusion,non obstructive CAD & expired from CHF.In all 66% of EC & 57% LC patients developed clinical abnormalities.
Conclusions: RT induced MP defects are associated with cardiac morbidity & mortality observed more frequently in esophageal cancer patients than in lung cancer.
| ||||||||||||||||||||||||||||||||||||||